The 2022 Jon van Rood award: selecting the Best Paper on immunological aspects of Allogeneic Hematopoietic Transplantation and other forms of Immune Effector Cell therapies.
Call for applications from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the EBMT.
The Jon van Rood award was created in the name of the late Jon van Rood, a long active immunologist who made seminal discoveries and observations in the field of cell and tissue transplants, in particular hematopoietic cell transplantation. In this early 21st century, hematopoietic cell transplantation stands strong as and appears as one of the first forms of cell-based immune therapy of hematological malignancies in the history of medicine. Recently, progress in cell and gene engineering have led to the approval and commercialization of innovative industry-manufactured medicinal products, some of which have resulted in the engineering of autologous or allogeneic immune effector cells with clinical efficacy in some disease subsets. To recognize these important changes, the scope of the Jon van Rood Award is now expanded to cover immunological aspects of hematopoietic cell transplantation as well as new developments in the design and evaluation of immune effector cell therapies.
The EBMT CTIWP is pleased to offer this prestigious (€ 5,000) award for outstanding contributions in the field of hematopoietic transplantation immunology, immunogenetics, tolerance, graft-vs-leukaemia/tumour effects, immune monitoring and development of innovative therapeutic approaches based on the engineering of immune effector cells.
The award will be presented during the Abstracts Awards session at the EBMT Annual Meeting. The selection will be undertaken by a distinguished international jury, led by experts from the CTIWP.
To qualify for the award your paper should have been published or accepted for publication during this year (2021) and you should not be older than 40 years on December 31st 2021.
Application guidelines
Applications for the award should include the following:
- Letter of application sent to Christian Chabannon, Chairperson CTIWP. c/o Centre de Thérapie Cellulaire. Centre d’Investigations Cliniques en Biothérapies Institut Paoli Calmettes. Marseille, France
- Applicant’s CV (including date of birth or age)
- Academic paper
Application should be submitted by email to both CTIWPebmt@lumc.nl and CHABANNONC@ipc.unicancer.fr.
Deadline to apply: 18 January, 2022
The Award of € 5,000 is generously supported by the EBMT with an unrestricted educational grant.